Skip to main content
Clinical Trials/JPRN-UMIN000005489
JPRN-UMIN000005489Completed未知

Effect of Pitavastatin on the coronary endothelial dysfunction after PCI with DES (Drug-eluting stent) - Effect of Pitavastatin on the coronary endothelial dysfunction after PCI with DES (Drug-eluting stent)

Hiroshima University hospital0 sites30 target enrollmentStarted: April 22, 2011Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.A PCI target lesion with graft disease or in-stent restenosis 2.Patients who have skip lesion without PCI target lesion, and planed PCI within this examination. But it does not limit the PCI by a disease of the right coronary artery 3.Stent which is BMS to use for PCI 4.Malignant tumor in active phase 5.Patients who meet contraindication of LIVALO tablet below a)Patients who have hypersensitivity to LIVALO tablet b)Patients who have severe liver dysfunction or biliary atresia c)Patients who are being treated with cyclosporine d)Pregnant women, women suspected of being pregnant, or lactating women 6.Patients with hypersensitive to contrast media 7.Patients with liver dysfunction [ALT(GPT) 100 IU/L <=] 8.Patients undergoing dialysis 9.Patients with familial hypercholesterolemia 10.Patients who are ineligible in the opinion of the investigator

Investigators

Similar Trials